
Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …

A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …

Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …

Novartis’s Tasigna (nilotinib) has received European Commission approval for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in …

A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …

Pfizer has announced that the FDA has expanded the use of its tyrosine kinase inhibitor Sutent (sunitinib malate) to include …

Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …

Boots, a UK high-street pharmacy, has come under pressure from Labour MPs after it failed to adhere to its own …

A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …

A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to …

The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for …

NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of …

Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …

It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk …